Company intelligence / Profile preview

Republic Capital Group

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Republic Capital is a multi-stage venture capital firm that invests in "Deep Tech," with a significant focus on the life sciences and biotechnology sectors. The firm targets ambitious companies working on transformative technologies such as cell and gene therapy, synthetic biology, and advanced diagnostics. Notable investments in the healthcare space include Sana Biotechnology, Ginkgo Bioworks, and Athelas. Republic Capital operates as the venture arm of the broader Republic investment platform, leveraging a global network to support its portfolio companies from early-stage development through to public markets.

Industry: Investors

Beyond the preview

Go deeper on Republic Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Republic Capital Group.

Explore the full profile